116 related articles for article (PubMed ID: 11428625)
1. Treatment of skin injuries induced by sulfur mustard with calmodulin antagonists, using the pig model.
Kadar T; Fishbeine E; Meshulam Y; Sahar R; Chapman S; Liani H; Barness I; Amir A
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S133-6. PubMed ID: 11428625
[TBL] [Abstract][Full Text] [Related]
2. Effects of calmodulin antagonists and anesthetics on the skin lesions induced by 2-chloroethylethyl sulfide.
Kim YB; Hur GH; Choi DS; Shin S; Han BG; Lee YS; Sok DE
Eur J Pharmacol; 1996 Oct; 313(1-2):107-14. PubMed ID: 8905336
[TBL] [Abstract][Full Text] [Related]
3. Characterization of acute and long-term sulfur mustard-induced skin injuries in hairless guinea-pigs using non-invasive methods.
Dachir S; Cohen M; Fishbeine E; Sahar R; Brandies R; Horwitz V; Kadar T
Skin Res Technol; 2010 Feb; 16(1):114-24. PubMed ID: 20384890
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous histopathologic features in weanling pigs after exposure to three different doses of liquid sulfur mustard.
Smith KJ; Skelton HG; Hobson DW; Reid FM; Blank JA; Hurst CG
Am J Dermatopathol; 1996 Oct; 18(5):515-20. PubMed ID: 8902098
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic approaches to dermatotoxicity by sulfur mustard. I. Modulaton of sulfur mustard-induced cutaneous injury in the mouse ear vesicant model.
Casillas RP; Kiser RC; Truxall JA; Singer AW; Shumaker SM; Niemuth NA; Ricketts KM; Mitcheltree LW; Castrejon LR; Blank JA
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S145-51. PubMed ID: 11428628
[TBL] [Abstract][Full Text] [Related]
6. Histopathologic features seen with different animal models following cutaneous sulfur mustard exposure.
Smith KJ; Casillas R; Graham J; Skelton HG; Stemler F; Hackley BE
J Dermatol Sci; 1997 Feb; 14(2):126-35. PubMed ID: 9039976
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effects of cooling swine skin exposed to sulfur mustard.
Sawyer TW; Nelson P; Hill I; Conley JD; Blohm K; Davidson C; Sawyer TW
Mil Med; 2002 Nov; 167(11):939-43. PubMed ID: 12448623
[TBL] [Abstract][Full Text] [Related]
8. Systemic administration of candidate antivesicants to protect against topically applied sulfur mustard in the mouse ear vesicant model (MEVM).
Babin MC; Ricketts K; Skvorak JP; Gazaway M; Mitcheltree LW; Casillas RP
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S141-4. PubMed ID: 11428627
[TBL] [Abstract][Full Text] [Related]
9. Hairless guinea pig bioassay model for vesicant vapor exposures.
Mershon MM; Mitcheltree LW; Petrali JP; Braue EH; Wade JV
Fundam Appl Toxicol; 1990 Oct; 15(3):622-30. PubMed ID: 2258024
[TBL] [Abstract][Full Text] [Related]
10. Detection and measurement of sulfur mustard offgassing from the weanling pig following exposure to saturated sulfur mustard vapor.
Logan TP; Graham JS; Martin JL; Zallnick JE; Jakubowski EM; Braue EH
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S199-204. PubMed ID: 11428637
[TBL] [Abstract][Full Text] [Related]
11. Potential anti-inflammatory treatments against cutaneous sulfur mustard injury using the mouse ear vesicant model.
Dachir S; Fishbeine E; Meshulam Y; Sahar R; Amir A; Kadar T
Hum Exp Toxicol; 2002 Apr; 21(4):197-203. PubMed ID: 12099621
[TBL] [Abstract][Full Text] [Related]
12. Medical management of cutaneous sulfur mustard injuries.
Graham JS; Stevenson RS; Mitcheltree LW; Hamilton TA; Deckert RR; Lee RB; Schiavetta AM
Toxicology; 2009 Sep; 263(1):47-58. PubMed ID: 18762227
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive methods for determining lesion depth from vesicant exposure.
Braue EH; Graham JS; Doxzon BF; Hanssen KA; Lumpkin HL; Stevenson RS; Deckert RR; Dalal SJ; Mitcheltree LW
J Burn Care Res; 2007; 28(2):275-85. PubMed ID: 17351445
[TBL] [Abstract][Full Text] [Related]
14. Reduction of erythema in hairless guinea pigs after cutaneous sulfur mustard vapor exposure by pretreatment with niacinamide, promethazine and indomethacin.
Yourick JJ; Dawson JS; Mitcheltree LW
J Appl Toxicol; 1995; 15(2):133-8. PubMed ID: 7782559
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of neutralized chemical agent identification sets (CAIS) for skin injury with an overview of the vesicant potential of agent degradation products.
Olajos EJ; Olson CT; Salem H; Singer AW; Hayes TL; Menton RG; Miller TL; Rosso T; MacIver B
J Appl Toxicol; 1998; 18(6):409-20. PubMed ID: 9840748
[TBL] [Abstract][Full Text] [Related]
16. Sulfur mustard-induced microvesication in hairless guinea pigs: effect of short-term niacinamide administration.
Yourick JJ; Dawson JS; Mitcheltree LW
Toxicol Appl Pharmacol; 1992 Nov; 117(1):104-9. PubMed ID: 1440603
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic and prophylactic treatment of skin burns with several calmodulin antagonists.
Beitner R; Chen-Zion M; Sofer-Bassukevitz Y; Oster Y; Ben-Porat H; Morgenstern H
Gen Pharmacol; 1989; 20(2):165-73. PubMed ID: 2714615
[TBL] [Abstract][Full Text] [Related]
18. A topical skin protectant against chemical warfare agents.
Kadar T; Fishbine E; Meshulam J; Sahar R; Amir A; Barness I
Isr Med Assoc J; 2003 Oct; 5(10):717-9. PubMed ID: 14719467
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of topical anti-inflammatory drugs against sulfur mustard-induced ocular lesions in rabbits.
Amir A; Turetz J; Chapman S; Fishbeine E; Meshulam J; Sahar R; Liani H; Gilat E; Frishman G; Kadar T
J Appl Toxicol; 2000 Dec; 20 Suppl 1():S109-14. PubMed ID: 11428620
[TBL] [Abstract][Full Text] [Related]
20. Effects of selected arginine analogues on sulphur mustard toxicity in human and hairless guinea pig skin keratinocytes.
Sawyer TW; Risk D
Toxicol Appl Pharmacol; 2000 Feb; 163(1):75-85. PubMed ID: 10662607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
